Cannabis Rescheduling Update: Everything You Need to Know
Stay informed with the latest update on the rescheduling of cannabis and understand its implications for purchasing THC products online.
Short answer: cannabis is still a Schedule I controlled substance under federal law. The DEA proposed moving marijuana to Schedule III in May 2024, and that proposal has not become a final rule. Until it does, the cannabis Schedule III update changes nothing for shoppers, dispensaries, or state-licensed online sellers.
Where the Schedule III update stands
The rescheduling question has moved through several stages, and each stage matters for how close a real change actually is.
- 2023: The Department of Health and Human Services completed a scientific review and recommended that the DEA place marijuana in Schedule III rather than Schedule I.
- May 2024: The DEA published a proposed rule in the Federal Register, which opened the proposal to public comment.
- Mid 2024: The comment window closed, and interested parties requested a formal administrative hearing.
- 2024 into 2025: A DEA administrative law judge gathered testimony and written evidence from supporters and opponents.
- Now: No final rule has taken effect. The proposal is still pending, and marijuana remains Schedule I in the interim.
Any final rule would appear in the Federal Register and take effect only after a set waiting period. Court challenges from either side are also possible, which can add months or years.
Cannabis Rescheduling vs Legalization: What Changes for Buyers
What would change if marijuana moves to Schedule III
Schedule III is not legalization. It is a reclassification. Drugs in this tier are recognized as having a currently accepted medical use and a lower potential for abuse than Schedule I or II substances.
Impact of Cannabis Rescheduling on Legality: A Comprehensive Guide
- Federal recognition of medical cannabis use, which currently exists only at the state level.
- Relief from the tax rule that blocks state-licensed cannabis businesses from claiming normal business deductions.
- Easier banking access for licensed operators, since federally insured banks face fewer compliance obstacles.
- Simplified clinical research, because Schedule I status creates extra registration and security requirements for studies.
What would not change
Rescheduling is narrower than most headlines suggest. State law would still control who can sell cannabis, where, and to whom.
- Recreational sales would not become federally legal.
- Shipping cannabis across state lines, including through the mail, would remain prohibited.
- Possession outside a state-regulated program would still be a federal offense, though penalties would be lower.
- State licensing, testing, labeling, and age rules would stay exactly as they are.
Why this matters if you buy cannabis online
The practical effect for shoppers is indirect. Rescheduling would not create a nationwide online cannabis marketplace, and no seller can legally mail THC products across state lines today. What it could eventually do is strengthen the licensed supply chain, since businesses would keep more of their revenue and gain better access to banking. Over time that can mean more stable inventory, more consistent testing, and less pressure to raise prices.
For now, ordering still works the same way it always has: you buy from a licensed operator in your own state, under your state's rules. Delivery windows, purchase limits, and product menus are set locally, not federally.
How to spot hype around rescheduling
A pending proposal invites exaggerated claims. A few habits keep you grounded.
- Treat any announcement of a "final" decision as unverified until a Federal Register entry exists.
- Ignore sellers who say rescheduling makes interstate shipping legal. It does not.
- Remember that Schedule III is still a controlled substance category, not a green light.
What to watch next
Three things determine the real outcome. First, the administrative law judge's recommendation and the DEA Administrator's final decision. Second, whether the final rule survives legal challenges. Third, whether Congress acts on its own, since legislation could move faster or slower than the agency process. Until one of those concludes, the honest status of the cannabis Schedule III update is simple: proposed, still pending, and not yet law.